antithrombin

  • n.抗凝血酶
antithrombinantithrombin
  1. The clinical significance of antithrombin ⅲ in patients with liver diseases

    抗凝血酶Ⅲ测定在肝脏病的临床意义

  2. The clinical significance of antithrombin ⅲ change in nephropathy syndrome patients

    肾病综合征患者抗凝血酶Ⅲ变化的临床意义

  3. Research St at us and Clinical Significance of Antithrombin

    抗凝血酶活性变化的研究及临床意义

  4. Analysis of the levels of plasma antithrombin in rats with acute lung injury

    急性肺损伤大鼠血浆抗凝血酶Ⅲ的变化

  5. Antithrombin activity was significantly decreased ( P < 0.001 ) .

    抗凝血酶活力显著降低(P<0.001)。

  6. The determination of antithrombin III in 238 cases of general surgical patients

    抗凝血酶Ⅲ因子(AT-Ⅲ)测定普外科疾病238例分析

  7. Measurement of Human Plasma Antithrombin - ⅲ in Thrombosis Diseases

    抗凝血酶Ⅲ测定在血栓形成性疾病中的诊断价值

  8. The preliminary study of the activity of plasma antithrombin ⅲ and protein C in diabetes patients

    糖尿病患者血浆抗凝血酶Ⅲ及蛋白C活性水平的初步探讨

  9. The Effect of SO_2 Plasma Treatment on Antithrombin of Polyurethane

    SO2等离子体处理对聚氨酯抗凝血性影响的研究

  10. Study and Clinical Significance of antithrombin ⅲ , Plasminogen and D-Dimer

    抗凝血酶III,纤溶酶原及D-二聚体的研究及临床意义

  11. Effect of exercise on antithrombin III and adhesive proteins in aged diabetic Patients

    运动对老年糖尿病人抗凝血酶Ⅲ及粘附蛋白的影响

  12. The study of the serum factor ⅱ and antithrombin activity in the patients with hepatocirrhosis

    肝硬化患者血浆凝血因子Ⅱ活性与抗凝血酶的研究

  13. Objective To investigate the diagnostic significance of detection of antithrombin activity in DIC .

    目的探讨抗凝血酶活性(AT:A)检测在诊断弥散性血管内凝血(DIC)中的意义。

  14. Significance of measurement of D-dimer concentration and antithrombin - ⅲ in lung cancer

    肺癌D-二聚体定量与抗凝血酶Ⅲ活性测定的意义

  15. A preliminary study on plasma antithrombin ⅲ in patients of left atrial myxoma

    左房粘液瘤患者血浆抗凝血酶Ⅲ的初步观察

  16. Study on Changes in Protein C System and Antithrombin ⅲ in Patients with Systemic Lupus Erythematosus

    系统性红斑狼疮患者蛋白C系统及抗凝血酶Ⅲ变化的研究

  17. Genetic Polymorphism of Antithrombin ⅲ in Five Chinese Populations

    中国5个群体抗凝血酶Ⅲ遗传多态性的研究

  18. Genetic polymorphism of antithrombin ⅲ in the Han population , Chengdu , China

    成都地区汉族群体抗凝血因子Ⅲ的遗传多态性

  19. Reduction in Serum Antithrombin ⅲ Level as an Indicator of Experimental Acute Hepatic Damage in Rats

    大鼠实验性急性肝损伤抗凝血酶Ⅲ的测定及意义

  20. Observation on Serum Antithrombin ⅲ level in Renal Diseases & An Analysis of Its Determination in 74 Cases

    肾脏疾病抗凝血酶Ⅲ的观察&附74例测定结果分析

  21. Evaluation of plasma antithrombin ⅲ quantity and activity in 98 cases with acute and chronic leukemia

    98例急性和慢性白血病患者血浆抗凝血酶Ⅲ含量及活性测定

  22. The observation activity of antithrombin ⅲ in acute leukemia

    急性白血病患者抗凝血酶Ⅲ活性观察

  23. Development Study of Inherited Antithrombin Deficiency

    遗传性抗凝血酶缺乏症研究进展

  24. Expression of Recombinant Human Antithrombin ⅲ ( AT - ⅲ ) in CHO Cells

    抗凝血酶Ⅲ(AT-Ⅲ)在CHO细胞表达

  25. ⅷ r : ag and antithrombin - ⅲ in patients with rheumatic heart disease

    风湿性心脏病因子Ⅷ相关抗原和抗凝血酶Ⅲ测定

  26. Purification of human antithrombin ⅲ and preparation of anti - antithrombin ⅲ serum

    人抗凝血酶Ⅲ及其抗血清的研制

  27. Correlation of platelet , antithrombin ⅲ and heparin tolerance in patients during cardiac surgery

    心脏手术病人血小板、抗凝血酶Ⅲ与肝素相对耐药的相关性

  28. Protective effect of gallic esters against hydroxyl radical damage on antithrombin ⅲ

    没食子酸酯对羟自由基损伤抗凝血酶Ⅲ的保护作用

  29. Conclusion This is a novel mutation , which can cause antithrombin deficiency and thrombosis .

    结论该突变是先天性抗凝血酶缺乏症的一个新的突变位点,可以导致血栓形成。

  30. Objective To identify the gene mutation of a kindred with type ⅰ antithrombin deficiency .

    目的对一先天性Ⅰ型抗凝血酶缺乏症家系进行基因突变的检测。